445 related articles for article (PubMed ID: 36652160)
1. Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
Harrison SR; Marzo-Ortega H
Curr Rheumatol Rep; 2023 Mar; 25(3):56-67. PubMed ID: 36652160
[TBL] [Abstract][Full Text] [Related]
2. Treatment overview of axial spondyloarthritis in 2023.
Baraliakos X; Kiltz U; Kononenko I; Ciurea A
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101858. PubMed ID: 37673758
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Ortolan A; Webers C; Sepriano A; Falzon L; Baraliakos X; Landewé RB; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):142-152. PubMed ID: 36261247
[TBL] [Abstract][Full Text] [Related]
5. Structural disease modification in axial spondyloarthritis.
Dinneen B; O'Shea F; Gensler L
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101898. PubMed ID: 38042689
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
7. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
8. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S; Nikiphorou E; Sepriano A; Ortolan A; Webers C; Baraliakos X; Landewé RBM; Van den Bosch FE; Boteva B; Bremander A; Carron P; Ciurea A; van Gaalen FA; Géher P; Gensler L; Hermann J; de Hooge M; Husakova M; Kiltz U; López-Medina C; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Nissen MJ; Pimentel-Santos FM; Poddubnyy D; Proft F; Rudwaleit M; Telkman M; Zhao SS; Ziade N; van der Heijde D
Ann Rheum Dis; 2023 Jan; 82(1):19-34. PubMed ID: 36270658
[TBL] [Abstract][Full Text] [Related]
9. Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI).
Maguire S; Fitzgerald G; Gallagher P; O'Shea F
Rheumatol Int; 2022 May; 42(5):831-838. PubMed ID: 35088133
[TBL] [Abstract][Full Text] [Related]
10. Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.
Zhao SS; Ermann J; Xu C; Lyu H; Tedeschi SK; Liao KP; Yoshida K; Moots RJ; Goodson NJ; Solomon DH
Rheumatology (Oxford); 2019 Nov; 58(11):2025-2030. PubMed ID: 31081033
[TBL] [Abstract][Full Text] [Related]
11. To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question.
Lukasik Z; Carron P; Webers C
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101869. PubMed ID: 37658017
[TBL] [Abstract][Full Text] [Related]
12. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Webers C; Ortolan A; Sepriano A; Falzon L; Baraliakos X; Landewé RBM; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):130-141. PubMed ID: 36270657
[TBL] [Abstract][Full Text] [Related]
14. Advances in pharmacotherapies for axial spondyloarthritis.
Toussirot E
Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
[TBL] [Abstract][Full Text] [Related]
15. Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Wang S; He Q; Shuai Z
Clin Rheumatol; 2018 Feb; 37(2):439-450. PubMed ID: 29290076
[TBL] [Abstract][Full Text] [Related]
16. [Axial spondyloarthritis : Update on management based on the interdisciplinary S3 guidelines on axial spondyloarthritis including early forms and ankylosing spondylitis].
Kiefer D; Braun J; Kiltz U
Z Rheumatol; 2022 Apr; 81(3):198-204. PubMed ID: 35113204
[TBL] [Abstract][Full Text] [Related]
17. Treatment of axial spondyloarthritis: an update.
Danve A; Deodhar A
Nat Rev Rheumatol; 2022 Apr; 18(4):205-216. PubMed ID: 35273385
[TBL] [Abstract][Full Text] [Related]
18. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
19. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
20. Treating spondyloarthritis early: does it matter? Results from a systematic literature review.
Capelusnik D; Benavent D; van der Heijde D; Landewé R; Poddubnyy D; van Tubergen A; Falzon L; Navarro-Compán V; Ramiro S
Rheumatology (Oxford); 2023 Apr; 62(4):1398-1409. PubMed ID: 36099043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
